Literature DB >> 21187480

E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium.

Elisabetta Carico1, Marco Atlante, Enrico Giarnieri, Salvatore Raffa, Barbara Bucci, Maria Rosaria Giovagnoli, Aldo Vecchione.   

Abstract

UNLABELLED: The aim of this study was to determine whether modulation of expression of cell adhesion molecules may occur in neoplastic transformation of endometrial epithelium.
MATERIALS AND METHODS: E-Cadherin and α-catenin protein expression were evaluated by immunohistochemistry in 124 biopsies representative of normal, hyperplastic and neoplastic endometrium.
RESULTS: In normal endometrium (proliferative, secretive and atrophic endometrium) strong homogeneous, E-cadherin and α-catenin reactivity was found; 58.3% and 66.6% of biopsies representative of simple hyperplastic endometrium were homogeneously positive for E-cadherin and α-catenin, respectively, whereas no samples representative of atypical hyperplasia showed evidence of homogeneous E-cadherin or α-catenin expression. No expression of homogeneous E-cadherin was seen in endometrial adenocarcinomas; α-catenin homogeneous immunostaining was observed in 2 G1 and 2 G2 out of 22 adenocarcinoma samples (18.2%). A homogeneous co-expression of both molecules was seen only in normal (70%) and simple hyperplastic (46%) endometrium.
CONCLUSION: These results suggest that E-cadherin and α-catenin down-regulation might be associated with neoplastic transformation of endometrial tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187480

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  The Chemical Potential of Plasma Membrane Cholesterol: Implications for Cell Biology.

Authors:  Artem G Ayuyan; Fredric S Cohen
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

2.  Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis.

Authors:  Xing Zheng; Xue-Lian Du; Tao Jiang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 3.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

4.  CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.

Authors:  A D Marshall; C G Bailey; K Champ; M Vellozzi; P O'Young; C Metierre; Y Feng; A Thoeng; A M Richards; U Schmitz; M Biro; R Jayasinghe; L Ding; L Anderson; E R Mardis; J E J Rasko
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

Review 5.  New concepts for an old problem: the diagnosis of endometrial hyperplasia.

Authors:  Peter A Sanderson; Hilary O D Critchley; Alistair R W Williams; Mark J Arends; Philippa T K Saunders
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

Review 6.  Direct Cell⁻Cell Interactions in the Endometrium and in Endometrial Pathophysiology.

Authors:  Susanne Grund; Ruth Grümmer
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

Review 7.  Memory T Cells in Pregnancy.

Authors:  Tom E C Kieffer; Anne Laskewitz; Sicco A Scherjon; Marijke M Faas; Jelmer R Prins
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

8.  Expression level of E-, N- and P-cadherin proteins in endometrial cancer.

Authors:  Łukasz Lewczuk; Anna Pryczynicz; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2021-02-04       Impact factor: 2.967

9.  MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma.

Authors:  Deanna D Dailey; Ann M Hess; Gerrit J Bouma; Dawn L Duval
Journal:  Front Vet Sci       Date:  2021-04-15

10.  Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer.

Authors:  Takeru Sugihara; Shunsuke Nakagawa; Yuko Sasajima; Takayuki Ichinose; Haruko Hiraike; Fukuo Kondo; Hiroshi Uozaki; Toshio Fukusato; Takuya Ayabe
Journal:  Br J Cancer       Date:  2016-03-22       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.